Sandoz

Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Novartis
Sandoz
biosimilars
generics
women executives
Flag link:
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Novartis
Sandoz
Evotec
biosimilars
Flag link:
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Novartis
Sandoz
generics
Adalvo
Flag link:
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
Flag link:
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Amgen
Otezla
immunology
generics
Sandoz
Zydus
patents
Flag link:
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
Endpoints
Sandoz
Allergan
Duke University
legal
patents
Latisse
Flag link:
Sandoz, betting on biosimilar sales, to build new production plant
Sandoz, betting on biosimilar sales, to build new production plant
BioPharma Dive
Sandoz
Novartis
drug manufacturing
Slovenia
biosimilars
Flag link:
Sandoz files biosimilar of Amgen osteoporosis drug in US
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Sandoz
Novartis
biosimilars
osteoporosis
Prolia
Xgeva
FDA
Flag link:
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Yahoo/Benzinga
Novartis
earnings
Sandoz
Flag link:
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Flag link:
JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says
JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says
Fierce Pharma
Novartis
JPMHC 2023
Sandoz
Respiratory
eye health
Flag link:
As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader
As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader
Fierce Pharma
Pharma CEOs
Teva Pharmaceutical
Kåre Schultz
Richard Francis
Sandoz
Flag link:
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
AbbVie
Orilissa
generics
Sandoz
Teva Pharmaceuticals
endometriosis
Flag link:
Sun, Camber join growing list of companies reporting Adderall supply problems
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
ADHD
Adderall
drug shortages
Sandoz
Sun Pharma
Novartis
Flag link:
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
generics
Europe
Teva Pharmaceutical
Sandoz
Flag link:
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Biogen
Novartis
Sandoz
biosimilars
Tysabri
MS
multiple sclerosis
Flag link:
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Novartis
Sandoz
clinical trials
biosimilarts
denosumab
osteoporosis
Flag link:
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Novartis
drug manufacturing
Sandoz
generics
Flag link:
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
spinoffs
Novartis
Sandoz
generics
Flag link:
FDA reviewing higher dose Hyrimoz biosimilar
FDA reviewing higher dose Hyrimoz biosimilar
Biopharma Reporter
FDA
Sandoz
biosimilars
Hyrimoz
Humira
AbbVie
Flag link:

Pages